Global scale advantage As part of Acacium Group, R&D Partners gains access to a global delivery footprint and additional workforce solutions. This enables cross selling of RPO MSP and related services to life sciences clients, increasing wallet share beyond staffing alone.

Lifecycle staffing The firm supports the entire drug and device lifecycle with FSP RPO MSP models, offering an integrated set of workforce solutions. This presents an opportunity to position R&D Partners as a single partner for discovery through manufacturing and commercialization, reducing vendor fragmentation.

Acquisition synergies The 2022 acquisition by Acacium Group creates integration opportunities to standardize processes and bundling of services. Use joint go to market initiatives to win larger programs and scale delivery across regions.

Regional focus Located in San Diego with a sizable workforce, the company can capitalize on the Southern California biotech cluster for rapid local staffing and MSP support. Target nearby life sciences firms with urgent hiring, compliance, and on site delivery needs.

Growth potential Revenue of 50-100 million indicates mid market scale and potential for expansion. Focus on mid market life sciences accounts and demonstrate ROI of end to end workforce solutions to attract larger, multi site engagements under Acacium umbrella.